Healthtech Startups

Panacea Medical Technologies manufactures radiation medical devices with extended product support and end-of-life management programs. The company emphasizes circular economy principles by designing products with 95% recyclable materials and coordinating responsible disposal of electronic, radioactive, and metal waste through authorized channels.

1 investor

Panalgo develops AI-powered analytics and real-world data access solutions for life sciences organizations to generate real-world evidence for clinical and commercial teams. The company serves healthcare payers, providers, and pharmaceutical firms with software and analytic services covering health economics outcomes research, epidemiology, and regulatory applications.

1 investor

Pando develops enzyme design and optimization using machine learning to accelerate the design-build-test-learn cycle for biotechnology applications.

1 investor

Panel Health builds an AI conversational bot and Natural Language Processing model to interview patients and analyze Real World Data, measuring Patient Experience (PREM) and delivering metrics and insights via a dashboard. It serves hospitals and clinics, medtech companies, and medical insurers.

1 investor

Pangea Biomed develops computational and data-driven platforms to advance precision oncology, helping researchers and clinicians select optimal cancer treatments and understand tumor biology. The company serves drug development teams, oncologists, and cancer centers globally.

1 investor

Pannex Therapeutics is developing Pannexin 1 (Panx1) channel blockers, a drug platform targeting pathological ATP release that drives neuroinflammation and immune dysregulation. Its therapeutics address unmet medical needs in neurology and oncology.

1 investor

Panoptive provides a software platform that continuously monitors clinical trials by converting monitoring reports and electronic data capture (EDC) data into structured findings, documented decisions, and audit-ready oversight records. The platform serves sponsors and clinical operations teams conducting regulated trials and helps organizations surface quality issues early while maintaining inspection-ready documentation.

1 investor

PanTheryx is a health and nutrition company that develops and commercializes consumer health supplements for the human health and wellness market, including products for digestive support and dietary needs.

1 investor

Papcup develops a non-invasive cervical screening platform using electrochemical biosensing technology to provide faster, more accessible diagnostics. The company targets women seeking cervical cancer screening and aims to expand its biosensor-based approach across broader healthcare diagnostics.

1 investor

Paper Plane Therapeutics develops virtual reality therapies to manage pain and anxiety in patients during medical procedures. The company licenses immersive VR solutions to hospitals, clinics, and care facilities.

1 investor

Parable develops software tools for wound care professionals that integrate modern data management and collaboration capabilities to improve clinical outcomes and reduce treatment costs.

1 investor

Paradigm Health is an Indiana-based hospice and palliative care provider offering community-based, holistic care to patients and support for their families and caregivers. It provides end-of-life hospice services, palliative care, bereavement support, volunteer programs, and enrichment offerings, and is accredited by the Accreditation Commission for Health Care.

1 investor

Paradigm Health provides technology and services that integrate with healthcare provider organizations to improve the clinical trial process. It works with providers and sponsors to increase patient enrollment and expand patient access to clinical trials.

1 investor

Paradigm Therapeutics is a biopharmaceutical company developing Zorblesia (SD-101), a proprietary topical whole-body therapy for treating the wounds, lesions, and infections associated with all subtypes of Epidermolysis Bullosa (EB), a rare genetic connective tissue disorder. The company focuses on discovering and delivering therapies for patients with serious, life-threatening diseases.

1 investor

Paragon 28 manufactures the PRECISION MIS Bunion System, a minimally invasive surgical instrument set for correcting bunion deformities through metatarsal osteotomy and fixation. The system is designed for orthopedic surgeons and hospitals performing bunion correction procedures.

1 investor

Paragonix Technologies develops, manufactures, and services organ preservation devices that combine cooling techniques with digital tracking and monitoring for clinicians managing donor organs during transplantation. It also maintains the GUARDIAN clinical registries, a database of organ preservation and post-transplant outcome data, serving the organ transplant industry.

1 investor

Parakeet Health offers a healthcare-native conversational AI platform that automates inbound and outbound patient access workflows—appointment scheduling, referral and fax processing, cancellation and no-show recovery, patient recall, and FAQs—across voice, SMS, fax, and email. It serves enterprise healthcare organizations and medical practices, integrating with EHR and practice management systems, and charges on a pay-for-performance model tied to verified revenue and cost outcomes.

1 investor

Parallel Health offers a skincare product line addressing aging through microbiome science, including peptide creams and cleansers designed to target the hallmarks of skin aging.

1 investor

Parasight develops in-clinic diagnostic laboratory systems for veterinary practices, enabling rapid automated analysis of fecal, blood, and urine samples with digital results in under six minutes. The systems support both companion and large animal practices through sample preparation, imaging, and measurement capabilities integrated with veterinary practice management software.

1 investor

Parata develops pharmacy automation solutions that help pharmacies improve efficiency, patient medication adherence, and operational costs. The company serves pharmacy teams managing medication packaging, delivery, and inventory across evolving market demands.

1 investor

Paratus builds intent-scored lead lists for companies selling into healthcare providers, using federal data and live web scraping to identify and qualify practices across the US market.

1 investor

ParcelShield provides temperature-controlled and protective shipping services for time-sensitive pharmaceutical and healthcare deliveries. The service adds a layer of protection to national and regional parcel shipments to ensure reliability across varying conditions and carriers.

1 investor

Pardes Biosciences develops oral medications designed to treat and prevent viral infections, including COVID-19.

1 investor

Parentune is an India-based online platform and mobile app that connects parents with a community of other parents and trusted experts for advice on children's health, nutrition, and well-being. It offers content, community meetups, and personalized parenting support, and reports over 1 million Android app downloads.

1 investor